Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide metered-dose inhaler in children with persistent asthma
2006-004740-22Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma and persistent asthma (3 arms), sponsored by Sanofi. Primary endpoint: Change from baseline to end of study in FEV1 percent predicted. Started Nov 2006; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2006-004740-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004740-22.